The Retina Group of New York is offering SYFOVRE™, a revolutionary treatment option for age-related dry macular degeneration (AMD) with geographic atrophy. We are thrilled to offer SYFOVRE to our ...
Objectives To identify changes in referral and treatment patterns of neovascular age-related macular degeneration with photodynamic therapy (PDT) within ophthalmology units in NHS hospitals and assess ...
The US Food and Drug Administration for the first time approved an implant to treat neovascular age-related macular degeneration (nAMD). By releasing a constant dose of ranibizumab, the implanted port ...
Charlotte Ophthalmic Practice Among First In The USA To Offer New Procedure To Prevent Vision Loss From Dry Macular Degeneration Metrolina Eye Associates continues to set new standards in leading-edge ...
-- Study will evaluate the safety and preliminary efficacy of AR-13503 SR Implant as monotherapy and in combination with aflibercept -- DURHAM, N.C.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc.
FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related ...
Patients with neovascular age-related macular degeneration who have not had treatment before for their disease had measurable improvements in visual acuity and key anatomical markers after 6 months of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback